Party at BIO conference that featured topless dancers draws fire from organization
One attendee called the PABNAB party entertainment "tone-deaf," but it's not the first event of its kind at a biotech show.
Gates Foundation debuts nonprofit biotech firm at BIO
The Gates Medical Research Institute will develop products for malaria, tuberculosis, enteric and diarrheal diseases.
Tips for Greater Healthcare Practice Success in 2025
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
CAR-T has a lot of promise, but some big challenges remain, experts at BIO, ASCO say
Many issues around CAR-T remain to be hashed out, but many experts pointed to infrastructure and clinics' capabilities as crucial.
Janssen sees a potential myeloma CAR-T edge, exec says at BIO
The company plans to open its upcoming trial of a Chinese-developed CAR-T at four initial sites later this year.
Gottlieb at BIO: FDA developing processes around right-to-try law
FDA commissioner gives clues of agency's right-to-try strategy in Q&A session during chat with BIO President Jim Greenwood.
Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies
CAR-Ts have generated excitement, but bispecific monoclonal antibodies may continue to have a competitive edge in some cases.
presented by
What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations
When it comes to managing inbound phone calls, underperformance has devastating cost implications.